"The faster it's sold the more production we can ramp
"The faster it's sold the more production we can ramp up."
Faster is good but there are no production facilities available that could absorb the approximate $2 Billion that the sale of present inventory would bring in.
Ken Chowder noted, "At the moment the Philippines has only 798 critical or severe cases, and about 25000 active cases, with about a thousand new cases a day. So a couple hundred thousand courses of Leron would go pretty far there.
Of course they would want to stockpile a bunch."
A couple hundred courses of Leronlimab X $1500 should get Cytodyn $300,000,000. That should be enough to get more production going and cover other Cytodyn costs!
I am not interested in exposing the "ineptness and corruption of the FDA." I am interested in getting approval for Leronlimab for all indications it can treat. The first one, however, opens a hell of a lot of doors. That is the priority. Other strategies risk burning bridges. That can't be risked.
You say you want to save lives yet you would risk non-approval of Leronlimab or even a slowdown?
If we sold all of our inventory as soon as possible, what would keep the FDA from saying, "Well, since you have no inventory, there is no urgency to your approval. We will set your application on the back burner and set the heat on low. Tell us when you can supply what you ask us to approve!"
In the meanwhile, other BPs are busily trying to emulate the MOA of Leronlimab with their mabs.
I am not saying American lives are anymore important then any other lives. You won't win this argument by floating slanderous charges.
All I am saying is you had better not try to end run the gov't. How many times do I have to say this? They could approve the sale of all present inventory BEFORE FDA approval! You don't know, I don't know. But what I do know is you had better think about that and ask!
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...
Continue Reading
Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...
Continue Reading
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...
Continue Reading
Top 5 Most Recently Viewed Articles
VinFast's Exciting Entry into the Gulf Region VinFast Auto recently marked an important milestone by officially launching its brand in the Gulf region, with a grand event on Bluewaters Island. This event showcased an array of innovative electric vehicles and signaled VinFast's commitment to sustainable mobility solutions within this vibrant market. Opening of the First...
Continue Reading
Pembina Pipeline Corporation Declares Quarterly Preferred Share Dividends Pembina Pipeline Corporation, known for its robust pipeline services, has officially announced that dividends for its preferred shares Series 1, 3, 5, 7, 9, 15, 17, 19, 21, and 25 will be declared by its Board of Directors. This announcement is significant for investors who hold these shares as it...
Continue Reading
Piper Sandler Welcomes New Managing Director Piper Sandler Companies (NYSE: PIPR), a well-respected investment bank, is pleased to share the news of Steve Tipler joining its financial sponsors group as a managing director. Based in the Minneapolis office, he brings valuable expertise to the team. Steve Tipler's Background Steve has more than 20 years of experience in the...
Continue Reading
Root Shakes Up the Market with Q4 Numbers Some earnings reports hit you like a ton of bricks, and then there's Root. On February 25, 2026, they dropped a bombshell after the bell. Beat the odds, and then some—this is the kind of performance that has investors sitting up and paying attention. Eye-Popping Earnings Performance Let’s break it down. Root obliterated the...
Continue Reading
Grindr Brings Holiday Cheer with Free Roam Access Grindr, the leading social platform for the LGBTQ+ community, is excited to announce that during the holiday season, users will have free access to its popular feature, Roam. This initiative is a wonderful gift for those looking to connect and explore while spreading cheer among friends and new acquaintances. Discovering...
Continue Reading